Changes in tubular biomarkers with dietary intervention and metformin in patients with autosomal dominant polycystic kidney disease: a post-hoc analysis of two clinical trials

Wei Wang,Zhiying You,Cortney N. Steele,Berenice Gitomer,Michel Chonchol,Kristen L. Nowak
DOI: https://doi.org/10.1186/s12882-024-03643-6
2024-06-26
BMC Nephrology
Abstract:Tubular biomarkers, which reflect tubular dysfunction or injury, are associated with incident chronic kidney disease and kidney function decline. Several tubular biomarkers have also been implicated in the progression of autosomal dominant polycystic kidney disease (ADPKD). We evaluated changes in multiple tubular biomarkers in four groups of patients with ADPKD who participated in one of two clinical trials (metformin therapy and diet-induced weight loss), based on evidence suggesting that such interventions could reduce tubule injury.
urology & nephrology
What problem does this paper attempt to address?